Boston Partners Biote Corp. Transaction History
Boston Partners
- $80.7 Billion
- Q1 2024
A detailed history of Boston Partners transactions in Biote Corp. stock. As of the latest transaction made, Boston Partners holds 713,741 shares of BTMD stock, worth $5.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
713,741
Previous 713,741
-0.0%
Holding current value
$5.33 Million
Previous $4.14 Million
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BTMD
# of Institutions
56Shares Held
12.8MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY3.77MShares$28.1 Million10.43% of portfolio
-
Bandera Partners LLC New York, NY2.01MShares$15 Million4.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$10.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY973KShares$7.27 Million0.0% of portfolio
-
Kanen Wealth Management LLC Coral Springs, FL838KShares$6.26 Million3.21% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $56.6M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...